ICBTIC/ISBT:

Jihong Chen1, Jiabiao Hong1, Kaiqiang Chen1

  • 1Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China.

PloS one
|November 13, 2025
PubMed
概括

混合逆优化 (HIPO) 是首选的宫癌支臂疗法,特别是在结合内腔和间歇设置 (IC/ISBT). 它减少了风险器官剂量,缩短了治疗时间,并改善了目标覆盖率,而不是手动规划和模拟化反向优化.